Sooji Lee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sooji Lee has a total of 91 co-authors. Here are the top co-authors by number of shared publications:
- Dong Keon Yon
Department of Medicine Kyung Hee University College of Medicine Seoul South Korea
19 shared publications - Hayeon Lee
Center for Digital Health, Medical Science Research Institute, Kyung Hee University Medical Center, Kyung Hee University College of Medicine, Seoul, South Korea
10 shared publications - Damiano Pizzol
Health Department, Eni Mozambique, Maputo, Mozambique
9 shared publications - Lee Smith
Centre for Health, Performance and Wellbeing Anglia Ruskin University Cambridge UK
9 shared publications - Jaeyu Park
Center for Digital Health, Medical Science Research Institute Kyung Hee University Medical Center, Kyung Hee University College of Medicine Seoul South Korea
8 shared publications - Ho Geol Woo
Department of Medicine, Kyung Hee University College of Medicine, Seoul, South Korea
7 shared publications
Latest Publications
- Open Access
- 4 September 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (36) , e50516
National trends in the prevalence of depression and suicidal ideation stratified by academic achievement among adolescents, 2006 to 2022 in South Korea
Although severe depression and suicidal ideation among adolescents could be driven by excessive academic competition, research on this problem is still insufficient. Therefore, this study aims to analyze the relationship between academic achievement, depression, and suicidal ideation based on large-scale data. This study utilized data from the nationwide Korea Youth Risk Behavior Web-based Survey conducted from 2006 to 2022, investigating a total of 1,138,802 adolescents. Weighted proportions with 95% confidence intervals (CIs) and crude numbers and percentages were utilized to analyze and present the results in various formats. To accurately assess the association of academic achievement with depression and suicidal ideation, weighted odds ratios and their 95% CIs were calculated using weighted logistic regression analysis. Compared to students with high academic achievement, those with moderate achievement showed a 1.12 (95% CI = 1.11–1.13) times higher risk of depression, while those with low achievement had a 1.54 (1.52–1.56) times higher risk. Similarly, students with low academic achievement had a 1.49 (95% CI = 1.47–1.51) times higher risk of suicidal ideation. The prevalence of both depression and suicidal ideation decreased before the coronavirus disease 2019 pandemic but steadily increased during the pandemic. Females experienced higher rates of depression in each academic achievement group (high: weighted odds ratio = 1.49 [95% CI = 1.46–1.52]; middle: 1.59 [1.56–1.63]; low: 1.72 [1.69–1.75]) and suicidal ideation (high: 1.60 [1.57–1.64]; middle: 1.63 [1.59–1.68]; low: 1.82 [1.78–1.86]) than males. This study suggests that academic achievement can be associated with depression and suicidal ideation. Therefore, implementing mental health and educational programs targeting students with lower academic achievement may be crucial.
- 4 September 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (36) , e50516
Open AccessNational trends in the prevalence of depression and suicidal ideation stratified by academic achievement among adolescents, 2006 to 2022 in South Korea
Although severe depression and suicidal ideation among adolescents could be driven by excessive academic competition, research on this problem is still insufficient. Therefore, this study aims to analyze the relationship between academic achievement, depression, and suicidal ideation based on large-scale data. This study utilized data from the nationwide Korea Youth Risk Behavior Web-based Survey conducted from 2006 to 2022, investigating a total of 1,138,802 adolescents. Weighted proportions with 95% confidence intervals (CIs) and crude numbers and percentages were utilized to analyze and present the results in various formats. To accurately assess the association of academic achievement with depression and suicidal ideation, weighted odds ratios and their 95% CIs were calculated using weighted logistic regression analysis. Compared to students with high academic achievement, those with moderate achievement showed a 1.12 (95% CI = 1.11–1.13) times higher risk of depression, while those with low achievement had a 1.54 (1.52–1.56) times higher risk. Similarly, students with low academic achievement had a 1.49 (95% CI = 1.47–1.51) times higher risk of suicidal ideation. The prevalence of both depression and suicidal ideation decreased before the coronavirus disease 2019 pandemic but steadily increased during the pandemic. Females experienced higher rates of depression in each academic achievement group (high: weighted odds ratio = 1.49 [95% CI = 1.46–1.52]; middle: 1.59 [1.56–1.63]; low: 1.72 [1.69–1.75]) and suicidal ideation (high: 1.60 [1.57–1.64]; middle: 1.63 [1.59–1.68]; low: 1.82 [1.78–1.86]) than males. This study suggests that academic achievement can be associated with depression and suicidal ideation. Therefore, implementing mental health and educational programs targeting students with lower academic achievement may be crucial.
- Open Access
- 30 June 2026
- Published by The Editorial Office of Gut and Liver in Gut and Liver
- Vol. 20 (4) , 681-693
Global, Regional, and National Burden of Liver Cancer from 1990 to 2021 and Projections to 2050: A Global Burden of Disease Study 2021
This study assessed the burden of liver cancer (LC) and its major risk factors from 1990 to 2021, with projections to 2050. The global and regional LC burden from 1990 to 2021 was extracted from the Global Burden of Disease Study 2021, and stratified by age, sex, Sociodemographic Index (SDI), region, and etiological category. Trends for the age-standardized mortality rate (ASMR) and age-standardized disability-adjusted life year rate (ASDR) were evaluated using estimated annual percentage changes. Attributable risk factors, including alcohol use, drug use, a high body mass index, tobacco use, and high fasting plasma glucose levels, were examined. Projections of the LC burden to 2050 were modeled under baseline and hypothetical risk elimination scenarios. The global ASMR of LC remained stable, from 5.86 per 100,000 population (95% uncertainty interval [UI], 5.38 to 6.46) in 1990 to 5.65 (95% UI, 5.13 to 6.30) in 2021. Regions with an initially high ASMR showed increases until the early 2000s, then decreased. The LC burden increased sharply with age and was consistently higher in males, particularly in high-SDI regions. Mortality varied by etiology, with hepatitis B virus as the leading cause, followed by hepatitis C virus and alcohol use. Major risk factors were alcohol and tobacco use among males and drug and alcohol use among females. By 2050, the ASMR and ASDR of LC are projected to reach 6.23 per 100,000 population (95% UI, 4.94 to 8.09) and 158.91 (95% UI, 125.34 to 210.28), respectively, but could decrease to 5.32 (95% UI, 4.21 to 6.95) and 135.33 (95% UI, 106.74 to 179.05) under improved metabolic and behavioral risk scenarios. Despite public health interventions, LC is estimated to maintain a significant global burden.
- 30 June 2026
- Published by The Editorial Office of Gut and Liver in Gut and Liver
- Vol. 20 (4) , 681-693
Open AccessGlobal, Regional, and National Burden of Liver Cancer from 1990 to 2021 and Projections to 2050: A Global Burden of Disease Study 2021
This study assessed the burden of liver cancer (LC) and its major risk factors from 1990 to 2021, with projections to 2050. The global and regional LC burden from 1990 to 2021 was extracted from the Global Burden of Disease Study 2021, and stratified by age, sex, Sociodemographic Index (SDI), region, and etiological category. Trends for the age-standardized mortality rate (ASMR) and age-standardized disability-adjusted life year rate (ASDR) were evaluated using estimated annual percentage changes. Attributable risk factors, including alcohol use, drug use, a high body mass index, tobacco use, and high fasting plasma glucose levels, were examined. Projections of the LC burden to 2050 were modeled under baseline and hypothetical risk elimination scenarios. The global ASMR of LC remained stable, from 5.86 per 100,000 population (95% uncertainty interval [UI], 5.38 to 6.46) in 1990 to 5.65 (95% UI, 5.13 to 6.30) in 2021. Regions with an initially high ASMR showed increases until the early 2000s, then decreased. The LC burden increased sharply with age and was consistently higher in males, particularly in high-SDI regions. Mortality varied by etiology, with hepatitis B virus as the leading cause, followed by hepatitis C virus and alcohol use. Major risk factors were alcohol and tobacco use among males and drug and alcohol use among females. By 2050, the ASMR and ASDR of LC are projected to reach 6.23 per 100,000 population (95% UI, 4.94 to 8.09) and 158.91 (95% UI, 125.34 to 210.28), respectively, but could decrease to 5.32 (95% UI, 4.21 to 6.95) and 135.33 (95% UI, 106.74 to 179.05) under improved metabolic and behavioral risk scenarios. Despite public health interventions, LC is estimated to maintain a significant global burden.
- Open Access
- 21 April 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (8) , e046746
Residential Greenness and Risk of Coronary Artery Disease Following COVID‐19: A Nationwide Cohort Study in South Korea
Background: Residential greenness has been associated with lower ischemic heart disease risk in general populations; however, its relevance after SARS‐CoV‐2 infection is unclear. We evaluated the associations between residential greenness and incident coronary artery disease following COVID‐19. Methods: In this nationwide cohort study using the South Korean K‐COV‐N (Korea Disease Control and Prevention Agency–COVID‐19–National Health Insurance Service) database, we included individuals aged ≥ 19 years with confirmed SARS‐CoV‐2 infection. The data set linked National Health Insurance Service health screening and claims data with Korea Disease Control and Prevention Agency surveillance records. Residential greenness was measured using the normalized difference vegetation index (NDVI; low 0.2– ≥ 0.6). The primary outcome was first diagnosis of coronary artery disease (acute coronary syndrome or chronic ischemic heart disease) ≥ 30 days after infection. Inverse probability of treatment weighting was used to balance covariates, and weighted Cox models were applied to estimate adjusted hazard ratios (aHRs) with 95% CIs. Analyses were stratified by COVID‐19 severity, vaccination status, variant period, sex, age, and income. Results: Among 3 097 179 individuals (61.4% men), 25.3%, 59.7%, and 15.0% were classified as having low, moderate, and high NDVI exposure, respectively. Although NDVI was not associated with risk of acute coronary syndrome, higher NDVI was associated with lower risk of chronic ischemic heart disease (aHR, 0.86 [95% CI, 0.84–0.88] for moderate NDVI; aHR, 0.82 [95% CI, 0.80–0.84] for high NDVI). Associations were stronger in moderate to severe COVID‐19, vaccinated individuals, males, and younger individuals. Conclusions: Residential greenness was not associated with post‐COVID acute coronary events but was consistently associated with lower chronic ischemic heart disease risk, suggesting a potential role in long‐term cardiovascular health after SARS‐CoV‐2 infection.
- 21 April 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (8) , e046746
Open AccessResidential Greenness and Risk of Coronary Artery Disease Following COVID‐19: A Nationwide Cohort Study in South Korea
Background: Residential greenness has been associated with lower ischemic heart disease risk in general populations; however, its relevance after SARS‐CoV‐2 infection is unclear. We evaluated the associations between residential greenness and incident coronary artery disease following COVID‐19. Methods: In this nationwide cohort study using the South Korean K‐COV‐N (Korea Disease Control and Prevention Agency–COVID‐19–National Health Insurance Service) database, we included individuals aged ≥ 19 years with confirmed SARS‐CoV‐2 infection. The data set linked National Health Insurance Service health screening and claims data with Korea Disease Control and Prevention Agency surveillance records. Residential greenness was measured using the normalized difference vegetation index (NDVI; low 0.2– ≥ 0.6). The primary outcome was first diagnosis of coronary artery disease (acute coronary syndrome or chronic ischemic heart disease) ≥ 30 days after infection. Inverse probability of treatment weighting was used to balance covariates, and weighted Cox models were applied to estimate adjusted hazard ratios (aHRs) with 95% CIs. Analyses were stratified by COVID‐19 severity, vaccination status, variant period, sex, age, and income. Results: Among 3 097 179 individuals (61.4% men), 25.3%, 59.7%, and 15.0% were classified as having low, moderate, and high NDVI exposure, respectively. Although NDVI was not associated with risk of acute coronary syndrome, higher NDVI was associated with lower risk of chronic ischemic heart disease (aHR, 0.86 [95% CI, 0.84–0.88] for moderate NDVI; aHR, 0.82 [95% CI, 0.80–0.84] for high NDVI). Associations were stronger in moderate to severe COVID‐19, vaccinated individuals, males, and younger individuals. Conclusions: Residential greenness was not associated with post‐COVID acute coronary events but was consistently associated with lower chronic ischemic heart disease risk, suggesting a potential role in long‐term cardiovascular health after SARS‐CoV‐2 infection.
- Top Cited PapersOpen Access
- 15 February 2026
- Published by Korean Pediatric Society in Clinical and Experimental Pediatrics
- Vol. 69 (2) , 171-181
Global and regional burden of neonatal disorders (preterm birth, encephalopathy, jaundice, and sepsis), 1990–2021 and projections to 2050
Background: Although most neonatal disorders are preventable, their global burden has not been comprehensively investigated in the context of underlying epidemiological patterns. Thus, here we conducted the first comprehensive assessment of the global burden of neonatal disorders and their 5 subtypes in 1990–2021 with projections through 2050.Purpose: To comprehensively assess the global burden of neonatal disorders in 1990–2021 and forecast trends through 2050 considering their significant contribution to infant mortality.Methods: We estimated the global burden of neonatal disorders (preterm birth, encephalopathy due to birth asphyxia and trauma, hemolytic disease and other neonatal jaundice types, sepsis, and other neonatal infections) and their attributable risk factors, including low birthweight, short gestation, household air pollution, and ambient particulate matter, using data from the Global Burden of Disease Study (GBD) 2021. Population attributable fractions were used to calculate the rates of age-standardized incidence (ASIR), mortality (ASMR), and disability-adjusted life years (ASDR) stratified by age, sex, sociodemographic index (SDI), and region. The disease burden forecasted through 2050 was evaluated by projection modeling using the GBD framework.Results: From 1990 to 2021, the ASIR, ASMR, and ASDR for neonatal disorders decreased: 466.94 (95% uncertainty interval, 461.65–473.62) to 437.43 (433.20–441.95), 46.06 (43.66–48.81) to 29.57 (25.37–34.26), and 4,343.25 (4,121.18–4,595.48) to 2,941.00 (2,547.76–3,384.20) per 100,000 population, respectively. Males (489.90 [484.15–495.69]) exhibited a higher rate of the age-standardized incidence for neonatal disorders. The burden of neonatal disorders was markedly higher in countries with lower SDI scores. Neonatal preterm birth is the leading cause of neonatal disorders in both sexes. Among 4 risk factors, a low birthweight contributed the most to the ASDR of neonatal disorders (2,227.54 [1,939.96–2,563.52]). The global ASDR for neonatal disorders is projected to decline from 2,022 (2,317.01 [1,982.04–2,700.43]) to 2,050 (1,230.57 [950.09–1,590.15]).Conclusion: Although the overall burden of neonatal disorders has decreased, substantial disparities have persisted across SDI levels with the highest burden observed in low-SDI countries. Among the subtypes, a preterm neonatal birth accounted for the highest burden, whereas a low birthweight was the most significant risk factor. To achieve global child health targets, it is essential to address regional disparities and promote equity in access to healthcare services and health outcomes.
- 15 February 2026
- Published by Korean Pediatric Society in Clinical and Experimental Pediatrics
- Vol. 69 (2) , 171-181
Top Cited PapersOpen AccessGlobal and regional burden of neonatal disorders (preterm birth, encephalopathy, jaundice, and sepsis), 1990–2021 and projections to 2050
Background: Although most neonatal disorders are preventable, their global burden has not been comprehensively investigated in the context of underlying epidemiological patterns. Thus, here we conducted the first comprehensive assessment of the global burden of neonatal disorders and their 5 subtypes in 1990–2021 with projections through 2050.Purpose: To comprehensively assess the global burden of neonatal disorders in 1990–2021 and forecast trends through 2050 considering their significant contribution to infant mortality.Methods: We estimated the global burden of neonatal disorders (preterm birth, encephalopathy due to birth asphyxia and trauma, hemolytic disease and other neonatal jaundice types, sepsis, and other neonatal infections) and their attributable risk factors, including low birthweight, short gestation, household air pollution, and ambient particulate matter, using data from the Global Burden of Disease Study (GBD) 2021. Population attributable fractions were used to calculate the rates of age-standardized incidence (ASIR), mortality (ASMR), and disability-adjusted life years (ASDR) stratified by age, sex, sociodemographic index (SDI), and region. The disease burden forecasted through 2050 was evaluated by projection modeling using the GBD framework.Results: From 1990 to 2021, the ASIR, ASMR, and ASDR for neonatal disorders decreased: 466.94 (95% uncertainty interval, 461.65–473.62) to 437.43 (433.20–441.95), 46.06 (43.66–48.81) to 29.57 (25.37–34.26), and 4,343.25 (4,121.18–4,595.48) to 2,941.00 (2,547.76–3,384.20) per 100,000 population, respectively. Males (489.90 [484.15–495.69]) exhibited a higher rate of the age-standardized incidence for neonatal disorders. The burden of neonatal disorders was markedly higher in countries with lower SDI scores. Neonatal preterm birth is the leading cause of neonatal disorders in both sexes. Among 4 risk factors, a low birthweight contributed the most to the ASDR of neonatal disorders (2,227.54 [1,939.96–2,563.52]). The global ASDR for neonatal disorders is projected to decline from 2,022 (2,317.01 [1,982.04–2,700.43]) to 2,050 (1,230.57 [950.09–1,590.15]).Conclusion: Although the overall burden of neonatal disorders has decreased, substantial disparities have persisted across SDI levels with the highest burden observed in low-SDI countries. Among the subtypes, a preterm neonatal birth accounted for the highest burden, whereas a low birthweight was the most significant risk factor. To achieve global child health targets, it is essential to address regional disparities and promote equity in access to healthcare services and health outcomes.
- Open Access
- 1 January 2026
- Published by XMLink in Journal of Korean Medical Science
- Vol. 41 (31)
Global Burden of Intracerebral Hemorrhage, 1990–2021, and Projections to 2050: A Global Burden of Disease Study 2021
Kim NY, et al. J Korean Med Sci. 2026 Aug;41(31):e210. https://doi.org/10.3346/jkms.2026.41.e210
- 1 January 2026
- Published by XMLink in Journal of Korean Medical Science
- Vol. 41 (31)
Open AccessGlobal Burden of Intracerebral Hemorrhage, 1990–2021, and Projections to 2050: A Global Burden of Disease Study 2021
Kim NY, et al. J Korean Med Sci. 2026 Aug;41(31):e210. https://doi.org/10.3346/jkms.2026.41.e210
- Open Access
- 1 January 2026
- Published by XMLink in Journal of Korean Medical Science
- Vol. 41 (35)
Global, Regional, and National Burden of Aortic Aneurysm, 1990–2021, and Projections to 2050
Jung M, et al. J Korean Med Sci. 2026 Sep;41:e237. https://doi.org/10.3346/jkms.2026.41.e237
- 1 January 2026
- Published by XMLink in Journal of Korean Medical Science
- Vol. 41 (35)
Open AccessGlobal, Regional, and National Burden of Aortic Aneurysm, 1990–2021, and Projections to 2050
Jung M, et al. J Korean Med Sci. 2026 Sep;41:e237. https://doi.org/10.3346/jkms.2026.41.e237
- Open Access
- 19 December 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (51) , e45960
Cardiovascular risk across stages of cardiovascular-kidney-metabolic syndrome in South Korea, 2002–2022: A population-based cohort study
Cardiovascular-kidney-metabolic (CKM) syndrome is an emerging global framework, but evidence on stage-specific cardiovascular risks remains limited. Therefore, we investigated the association between CKM syndrome stages and cardiovascular outcomes, accounting for confounders and identifying the most influential components. This study utilized data from the Ansan – Ansung cohort, a longitudinal population-based cohort study conducted in South Korea from 2002 to 2022. CKM syndrome was classified according to the American Heart Association guidelines using the Predicting Risk of Cardiovascular Disease EVENTs equations into 4 stages: stage 0 (healthy), stage 1 (early risk), stage 2 (intermediate risk), and stage 3 (severe). A Cox proportional hazards model with time-varying covariates was applied to evaluate the associations between CKM syndrome stages and cardiovascular outcomes, including cerebrovascular disease, coronary artery disease, and myocardial infarction. Among the 9373 participants (47.2% male), 1074 (11.5%) were in stage 0, 1919 (20.5%) in stage 1, 3791 (40.5%) in stage 2, and 2589 (27.6%) in stage 3. Compared with stage 0, the risk of cardiovascular diseases was significantly increased in stage 2 (adjusted hazard ratio, 1.18 [95% confidence interval 1.03–1.38]) and stage 3 (1.26 [1.05–1.50]), whereas stage 1 showed no significant association. Among the underlying CKM conditions, hypertension exhibited the strongest association with all 3 outcomes: cerebrovascular disease (1.50 [1.34–1.67]), coronary artery disease (1.40 [1.22–1.60]), and myocardial infarction (1.43 [1.18–1.75]). Overall, this cohort study indicates that higher CKM syndrome stages are associated with increased cardiovascular risks. These findings underscore the importance of comprehensive, multidisciplinary strategies in clinical management and public health policies to reduce the burden of CKM syndrome and its related cardiovascular risks.
- 19 December 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (51) , e45960
Open AccessCardiovascular risk across stages of cardiovascular-kidney-metabolic syndrome in South Korea, 2002–2022: A population-based cohort study
Cardiovascular-kidney-metabolic (CKM) syndrome is an emerging global framework, but evidence on stage-specific cardiovascular risks remains limited. Therefore, we investigated the association between CKM syndrome stages and cardiovascular outcomes, accounting for confounders and identifying the most influential components. This study utilized data from the Ansan – Ansung cohort, a longitudinal population-based cohort study conducted in South Korea from 2002 to 2022. CKM syndrome was classified according to the American Heart Association guidelines using the Predicting Risk of Cardiovascular Disease EVENTs equations into 4 stages: stage 0 (healthy), stage 1 (early risk), stage 2 (intermediate risk), and stage 3 (severe). A Cox proportional hazards model with time-varying covariates was applied to evaluate the associations between CKM syndrome stages and cardiovascular outcomes, including cerebrovascular disease, coronary artery disease, and myocardial infarction. Among the 9373 participants (47.2% male), 1074 (11.5%) were in stage 0, 1919 (20.5%) in stage 1, 3791 (40.5%) in stage 2, and 2589 (27.6%) in stage 3. Compared with stage 0, the risk of cardiovascular diseases was significantly increased in stage 2 (adjusted hazard ratio, 1.18 [95% confidence interval 1.03–1.38]) and stage 3 (1.26 [1.05–1.50]), whereas stage 1 showed no significant association. Among the underlying CKM conditions, hypertension exhibited the strongest association with all 3 outcomes: cerebrovascular disease (1.50 [1.34–1.67]), coronary artery disease (1.40 [1.22–1.60]), and myocardial infarction (1.43 [1.18–1.75]). Overall, this cohort study indicates that higher CKM syndrome stages are associated with increased cardiovascular risks. These findings underscore the importance of comprehensive, multidisciplinary strategies in clinical management and public health policies to reduce the burden of CKM syndrome and its related cardiovascular risks.
- Open Access
- 25 November 2025
- Published by Korean Neuropsychiatric Association in Psychiatry Investigation
- Vol. 22 (11) , 1277-1289
Global Burden of Depressive Disorders, 1990–2021, During the COVID-19 Pandemic and Projections to 2050: A Global Burden of Disease Study 2021
Objective Despite an increase in the depressive disorders burden during the coronavirus disease-2019 (COVID-19) pandemic, research remains insufficient. This study aims to advance the understanding of the global depressive disorders burden, focusing on the COVID-19 pandemic.Methods Global and regional estimates of incidence, prevalence, and disability-adjusted life years (DALYs) for depressive disorders from 1990 to 2021 were analyzed using the Global Burden of Disease Study 2021. Depressive disorders were defined as the aggregate of major depressive disorder and dysthymia. Estimates were stratified by age, sex, Socio-demographic Index (SDI), and region, and trends were assessed by annual percent change. Attributable risk factors and projections to 2050 were assessed by modeling risk factors.Results In 2021, depressive disorders accounted for 56,330.36 (95% uncertainty interval [UI], 39,339.99 to 76,538.17) DALYs. The age-standardized DALYs rate (ASDR) remained stable until 2019, followed by an increase during the COVID-19 pandemic (ASDR in 1990: 600.51 [95% UI, 420.94 to 818.45] per 100,000; in 2019: 593.50 [413.34 to 810.07]; in 2021: 681.14 [475.19 to 923.83]). The highest ASDRs were observed in low (837.53 [95% UI, 569.85 to 1,140.07] per 100,000) and low-middle (784.07 [542.47 to 1,059.21]) SDI regions. The burden increased rapidly among adolescents and remained higher in females than in males. The burden attributable to intimate partner violence increased during the COVID-19 pandemic. Projections suggest a modest decline in global ASDR, reaching 622.30 (95% UI, 430.96 to 847.82) per 100,000 by 2050.Conclusion The global burden of depressive disorders increased sharply during the COVID-19 pandemic. It is essential to address regional disparities in mental health care and promote access to tailored treatment.
- 25 November 2025
- Published by Korean Neuropsychiatric Association in Psychiatry Investigation
- Vol. 22 (11) , 1277-1289
Open AccessGlobal Burden of Depressive Disorders, 1990–2021, During the COVID-19 Pandemic and Projections to 2050: A Global Burden of Disease Study 2021
Objective Despite an increase in the depressive disorders burden during the coronavirus disease-2019 (COVID-19) pandemic, research remains insufficient. This study aims to advance the understanding of the global depressive disorders burden, focusing on the COVID-19 pandemic.Methods Global and regional estimates of incidence, prevalence, and disability-adjusted life years (DALYs) for depressive disorders from 1990 to 2021 were analyzed using the Global Burden of Disease Study 2021. Depressive disorders were defined as the aggregate of major depressive disorder and dysthymia. Estimates were stratified by age, sex, Socio-demographic Index (SDI), and region, and trends were assessed by annual percent change. Attributable risk factors and projections to 2050 were assessed by modeling risk factors.Results In 2021, depressive disorders accounted for 56,330.36 (95% uncertainty interval [UI], 39,339.99 to 76,538.17) DALYs. The age-standardized DALYs rate (ASDR) remained stable until 2019, followed by an increase during the COVID-19 pandemic (ASDR in 1990: 600.51 [95% UI, 420.94 to 818.45] per 100,000; in 2019: 593.50 [413.34 to 810.07]; in 2021: 681.14 [475.19 to 923.83]). The highest ASDRs were observed in low (837.53 [95% UI, 569.85 to 1,140.07] per 100,000) and low-middle (784.07 [542.47 to 1,059.21]) SDI regions. The burden increased rapidly among adolescents and remained higher in females than in males. The burden attributable to intimate partner violence increased during the COVID-19 pandemic. Projections suggest a modest decline in global ASDR, reaching 622.30 (95% UI, 430.96 to 847.82) per 100,000 by 2050.Conclusion The global burden of depressive disorders increased sharply during the COVID-19 pandemic. It is essential to address regional disparities in mental health care and promote access to tailored treatment.
- 30 October 2025
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 47 (3) , 382-383
Methodological considerations and challenges in zoster vaccination and cardiovascular research
- 30 October 2025
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 47 (3) , 382-383
Methodological considerations and challenges in zoster vaccination and cardiovascular research
- Open Access
- 15 August 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (33) , e43773
National trends in hypertension stratified by central adiposity using waist-to-height ratio in South Korea, 2005 to 2022
Despite the growing prevalence of hypertension due to lifestyle changes and aging populations, with central obesity as a critical risk factor, there is limited research examining the association between central adiposity and hypertension trends. To address this gap, this study analyzed trends in hypertension prevalence among Korean adults categorized by healthy and increased central adiposity based on waist-to-height ratio (WHtR) and investigated the associated risk factors. We utilized data from 98,396 adults aged 30 years and older from the Korea National Health and Nutrition Examination Survey from 2005 to 2022 in South Korea. Participants were categorized into 2 groups according to central adiposity: low-WHtR group (diff , and adjusted odds ratios with 95% confidence intervals. From 2005 to 2019, the prevalence of hypertension increased in both low and high-WHtR groups, with a more pronounced increase in the increased central obesity group. Notably, the prevalence was higher in males than in females in the low-WHtR group (20.47% in males vs 12.33% in females), but similar in both sexes in the high-WHtR group (43.44% vs 41.74%). Furthermore, subgroup analyses showed that females aged 30–59 years in the high-WHtR group had higher odds of hypertension than males, whereas males aged 60 years and older had higher odds than females. This study suggests that the association between central obesity and hypertension risk varies significantly across age and sex categories, highlighting the necessity for age- and sex-specific prevention and management strategies.
- 15 August 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (33) , e43773
Open AccessNational trends in hypertension stratified by central adiposity using waist-to-height ratio in South Korea, 2005 to 2022
Despite the growing prevalence of hypertension due to lifestyle changes and aging populations, with central obesity as a critical risk factor, there is limited research examining the association between central adiposity and hypertension trends. To address this gap, this study analyzed trends in hypertension prevalence among Korean adults categorized by healthy and increased central adiposity based on waist-to-height ratio (WHtR) and investigated the associated risk factors. We utilized data from 98,396 adults aged 30 years and older from the Korea National Health and Nutrition Examination Survey from 2005 to 2022 in South Korea. Participants were categorized into 2 groups according to central adiposity: low-WHtR group (diff , and adjusted odds ratios with 95% confidence intervals. From 2005 to 2019, the prevalence of hypertension increased in both low and high-WHtR groups, with a more pronounced increase in the increased central obesity group. Notably, the prevalence was higher in males than in females in the low-WHtR group (20.47% in males vs 12.33% in females), but similar in both sexes in the high-WHtR group (43.44% vs 41.74%). Furthermore, subgroup analyses showed that females aged 30–59 years in the high-WHtR group had higher odds of hypertension than males, whereas males aged 60 years and older had higher odds than females. This study suggests that the association between central obesity and hypertension risk varies significantly across age and sex categories, highlighting the necessity for age- and sex-specific prevention and management strategies.